Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110393993 | 11039399 | 3 | F | 2015 | 20160913 | 20150416 | 20160919 | PER | US-ALEXION-A201501300 | ALEXION | 0.00 | Y | 0.00000 | 20160919 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110393993 | 11039399 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | U | T2-AD3745B01 | 125166 | CONCENTRATE FOR SOLUTION FOR INFUSION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 110393993 | 11039399 | 1 | Haemolytic uraemic syndrome |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 110393993 | 11039399 | Abdominal pain | |
| 110393993 | 11039399 | Anal incontinence | |
| 110393993 | 11039399 | Diarrhoea | |
| 110393993 | 11039399 | Eye pain | |
| 110393993 | 11039399 | Fatigue | |
| 110393993 | 11039399 | Gastrointestinal bacterial overgrowth | |
| 110393993 | 11039399 | Headache | |
| 110393993 | 11039399 | Malaise | |
| 110393993 | 11039399 | Menorrhagia | |
| 110393993 | 11039399 | Nasal congestion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |